Approval · Notice of Compliance 9932 · 2008
GLYCON: Notice of Compliance 9932
Issued December 10, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9932
- Date
- December 10, 2008
- Company
- Valeant Canada LpLaval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- PM update as per TPD's request.
- Therapeutic class
- Oral antihyperglycemic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GLYCON | Not yet assigned | — |
Medicinal ingredients
- METFORMIN HYDROCHLORIDE 500 MG per TAB
- METFORMIN HYDROCHLORIDE 850 MG per TAB